Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 102, Issue 51, 2005, Pages 18538-18543

  Sato, Eiichi ^a,f   Olson, Sara H ^a   Ahn, Jiyoung ^b,c   Bundy, Brian ^b   Nishikawa, Hiroyoshi ^a   Qian, Feng ^b   Jungbluth, Achim A ^a   Frosina, Denise ^a   Gnjatic, Sacha ^a   Ambrosone, Christine ^b   Kepner, James ^b   Odunsi, Tosin ^c   Ritter, Gerd ^a   Lele, Shashikant ^b   Chen, Yao Tseng ^d   Ohtani, Haruo ^e   Old, Lloyd J ^a   Odunsi, Kunle ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c Cornell University ^*  (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e NATIONAL HOSPITAL ORGANIZATION MITO MEDICAL CENTER   (Japan)

^f TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Cancer testis antigen; CD8+ T cell

Indexed keywords

CANCER TESTIS ANTIGEN; MELANOMA ANTIGEN; NY ESO 1 ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REGULATORY T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; AGED, 80 AND OVER; CD4-CD8 RATIO; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; SURVIVAL RATE; T-LYMPHOCYTES, REGULATORY;

EID: 29444442811     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0509182102     Document Type: Article

References (31)

1. Clemente, C. G., Mihm, M. C, Jr., Bufalino, R., Zurrida, S., Collini, P. & Cascinelli, N. (1996) Cancer 77, 1303-1310.
2. Jass, J. R. (1986) J. Clin. Pathol. 39, 585-589.
3. Naito, Y., Saito, K., Shiiba, K., Ohuchi, A., Saigenji, K., Nagura, H. & Ohtani, H. (1998) Cancer Res. 58, 3491-3494.
4. Schumacher, K., Haensch, W., Roefzaad, C. & Schlag, P. M. (2001) Cancer Res. 61, 3932-3936.
5. Nakano, O., Sato, M., Naito, Y., Suzuki, K., Orikasa, S., Aizawa, M., Suzuki, Y., Shintaku, I., Nagura, H. & Ohtani, H. (2001) Cancer Res. 61, 5132-5136.
6. Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) N. Engl. J. Med. 348, 203-213.
7. Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) Nat. Med. 10, 942-949.
8. McGuire, W. P., Hoskins, W. J., Brady, M. F., Kucera, P. R., Partridge, E. E., Look, K. Y., Clarke-Pearson, D. L. & Davidson, M. (1996) Semin. Oncol 23, 40-47.
9. Vaidya, A. P. & Curtin, J. P. (2003) Semin. Oncol. 30, 401-412.
10. Boon, T., Cerottini, J. C., Van den Eynde, B., van der Bruggen, P. & Van Pel, A. (1994) Annu. Rev. Immunol. 12, 337-365.
11. Old, L. J. & Chen, Y. T. (1998) J. Exp. Med. 187, 1163-1167.
12. Scanlan, M. J., Gure, A. O., Jungbluth, A. A., Old, L. J. & Chen, Y. T. (2002) Immunol. Rev. 188, 22-32.
13. Odunsi, K., Jungbluth, A. A., Stockert, E., Qian, F., Gnjatic, S., Tammela, J., Intengan, M., Beck, A., Keitz, B., Santiago, D., et al. (2003) Cancer Res. 63, 6076-6083.
14. Gillespie, A. M., Rodgers, S., Wilson, A. P., Tidy, J., Rees, R. C., Coleman, R. E. & Murray, A. K. (1998) Br. J. Cancer 78, 816-821.
15. Yakirevich, E., Sabo, E., Lavie, O., Mazareb, S., Spagnoli, G. C. & Resnick, M. B. (2003) Clin. Cancer Res. 9, 6453-6460.
16. Chen, Y. T., Stocken, E., Chen, Y., Garin-Chesa, P., Rettig, W. J., van der Bruggen, P., Boon, T. & Old, L. J. (1994) Proc. Natl. Acad. Sci. USA 91, 1004-1008.
17. Kocher, T., Schultz-Thater, E., Gudat, F., Schaefer, C., Casorati, G., Juretic, A., Willimann, T., Harder, F., Heberer, M. & Spagnoli, G. C. (1995) Cancer Res. 55, 2236-2239.
18. Landry, C., Brasseur, F., Spagnoli, G. C., Marbaix, E., Boon, T., Coulie, P. & Godelaine, D. (2000) Int. J. Cancer 86, 835-841.
19. Lan, H. Y., Mu, W., Nikolic-Paterson, D. J. & Atkins, R. C. (1995) J. Histochem. Cytochem. 43, 97-102.
20. Holschneider, C. H. & Berek, J. S. (2000) Semin. Surg. Oncol. 19, 3-10.
21. Engel, J., Eckel, R., Schubert-Fritschle, G., Kerr, J., Kuhn, W., Diebold, J., Kimmig, R., Rehbock, J. & Holzel, D. (2002) Eur. J. Cancer 38, 2435-2445.
22. Hori, S., Nomura, T. & Sakaguchi, S. (2003) Science 299, 1057-1061.
23. Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. (2003) Nat. Immunol. 4, 330-336.
24. Dunn, G. P., Old, L. J. & Schreiber, R. D. (2004) Immunity 21, 137-148.
25. Diederichsen, A. C., Hjelmborg, J. B., Christensen, P. B., Zeuthen, J. & Fenger, C. (2003) Cancer Immunol. Immunother. 52, 423-428.
26. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. (1995) J. Immunol. 155, 1151-1164.
27. Sakaguchi, S. (2004) Annu. Rev. Immunol. 22, 531-562.
28. Shevach, E. M. (2002) Nat. Rev. Immunol. 2, 389-400.
29. Woo, E. Y., Chu, C. S., Goletz, T. J., Schlienger, K., Yeh, H., Coukos, G., Rubin, S. C., Kaiser, L. R. & June, C. H. (2001) Cancer Res. 61, 4766-4772.
30. Lutsiak, M. E., Semnani, R. T., De Pascalis, R., Kashmiri, S. V., Schlom, J. & Sabzevari, H. (2005) Blood 105, 2862-2868.
31. Ghiringhelli, F., Larmonier, N., Schmitt, E., Parcellier, A., Cathelin, D., Garrido, C., Chauffert, B., Solary, E., Bonnette, B. & Martin, F. (2004) Eur. J. lmmunol. 34, 336-344.